Park Square is delighted to announce the placement of Steven Metzger as Vice President, Diagnostics at Xilis. Metzger is an experienced developer of cell-based diagnostic products, having most recently served as an early employee of Accelerate Diagnostics. There he drove, from inception, the company’s flagship platform through the De Novo 510K process to successful clearance by the FDA and registration in EMEA markets. Metzger’s efforts led to the development and launch of several novel tests which have dramatically improved the treatment selection for patients at-risk for sepsis and other critical infectious diseases. Metzger received his B.A. in chemistry from Colorado College.

https://xilis.com/about-us/leadership/